LEVOLEUCOVORIN

Generic: LEVOLEUCOVORIN

Hikma Pharmaceuticals USA Inc.Manufacturer
INTRAVENOUSRoute
LEVOLEUCOVORIN CALCIUMActive Substance
2016-06-16Original Approval

LEVOLEUCOVORIN is FDA application ANDA206263, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
NAUSEA
288 reports
2
OFF LABEL USE
276 reports
3
NEUTROPENIA
251 reports
4
DIARRHOEA
246 reports
5
DECREASED APPETITE
187 reports
6
VOMITING
171 reports
7
MALIGNANT NEOPLASM PROGRESSION
163 reports
8
NEUROPATHY PERIPHERAL
153 reports
9
PYREXIA
139 reports
10
ASTHENIA
136 reports